ClinicalTrials.govpublic full text
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
glioblastoma, glioblastoma, idh-wildtype, gliosarcoma, recurrent glioblastoma, idh-wildtype, recurrent gliosarcoma, resectable glioblastoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 801025
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.